Fabio Franco

发表

To burn-out or not to burn-out: a cross-sectional study in healthcare professionals in Spain during COVID-19 pandemic

M. Provencio, A. Collazo-Lorduy, E. Menasalvas, 2021, BMJ Open.

Next-generation sequencing for tumor mutation quantification using liquid biopsies

V. Calvo, M. Provencio, Fabio Franco, 2019, Clinical chemistry and laboratory medicine.

Neoadjuvant chemo-immunotherapy for the treatment of stage IIIA resectable non-small-cell lung cancer (NSCLC): A phase II multicenter exploratory study—Final data of patients who underwent surgical assessment.

N. Viñolas, B. Massuti, M. Provencio, 2019, Journal of Clinical Oncology.

Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation

C. García-Girón, J. Bosch-Barrera, M. Provencio, 2022, Cancers.

Some unanswered questions about older adults with metastatic pancreatic cancer.

Fabio Franco, A. Ruiz-Casado, M. González-Haba, 2020, Journal of geriatric oncology.

On Predicting Recurrence in Early Stage Non-small Cell Lung Cancer

Sameh K. Mohamed, Pontus Stenetorp, Pasquale Minervini, 2021, AMIA.

Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors

V. Calvo, M. Provencio, A. Collazo-Lorduy, 2022, Frontiers in Cardiovascular Medicine.

Chronodisruption and Ambulatory Circadian Monitoring in Cancer Patients: Beyond the Body Clock

M. Provencio, M. Torrente, P. Sousa, 2022, Current Oncology Reports.

Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection.

B. Massuti, M. Provencio, Fabio Franco, 2021, Lung cancer.

Integrating immune checkpoint inhibitors and targeted therapies in the treatment of early stage non-small cell lung cancer: a narrative review

V. Calvo, M. Provencio, Fabio Franco, 2020, Translational lung cancer research.

Clinical factors influencing long-term survival in a real-life cohort of early stage non-small-cell lung cancer patients in Spain

Gracinda R. Guerreiro, M. Provencio, M. Torrente, 2023, Frontiers in Oncology.

Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of 90Y‐DOTA‐D‐Phe1‐Tyr3 octreotide

A. Zaniboni, Fabio Franco, F. Bertagna, 2012, Cancer.

Understanding prognosis and survival outcomes in patients with early-stage non-small-cell lung cancer.

Gracinda R. Guerreiro, M. Provencio, M. Torrente, 2022, Clinical medicine.

Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment.

C. García-Girón, J. Bosch-Barrera, M. Provencio, 2021, European journal of cancer.

Association of quality of life with performance status, circadian rhythm, and activity level of lung cancer patients using wearable devices as ambulatory monitoring.

V. Calvo, M. Provencio, M. Torrente, 2022, Clinical medicine (London).

IASIS and BigMedilytics: Towards personalized medicine in Europe pdf

Ernestina Menasalvas Ruiz, Massimiliano Zanin, Consuelo Gonzalo-Martín, 2018, ArXiv.

Final Results of a Phase 2A Study for the Treatment of Metastatic Neuroendocrine Tumors With a Fixed Activity of

A. Zaniboni, Fabio Franco, F. Bertagna, 2012 .